Contract manufacturing to serve the global market

Established in 2003, Cell Therapies Pty Ltd (CTPL) is one of the most experienced cGMP compliant manufacturers for cell therapies, gene therapies, cellular immunotherapies and regenerative medicine products globally.  CTPL offers:

  • Contract Development and Manufacturing (CDMO) of cell-based therapies to meet global regulatory requirements for clinical trials and commercial supply
  • Apheresis collection protocol development, collection site assessment and establishment, and collection network management
  • Clinical trial support, including assistance with clinical trial design, protocol development, regulatory submission, and imaging/tracking of cells after patient infusion
  • Consulting and advisory services, with specific focus on manufacturing, testing, clinical design strategy, regulatory submission, and quality management

 

Our services are customised to enable clients to meet their strategic goals, which requires an initial consult with our experts.  Please contact us today to get started.